This contract expires in 141 days (Oct 31, 2026).
FIRM FIXED PRICE
NOVARTIS PHARMACEUTICALS CORPORATION - PLUVICTO AND LUTATHERA
PIID: 36C26226N0112
Signed Date: Oct 8, 2025Effective Date: Nov 1, 2025End Date: Closes in 141 days
Award $
$3.9M
Vendor
NOVARTIS PHARMACEUTICALS CORPORATION
NAICS
325412
Signed Date
Oct 8, 2025
Key Details
Description
PLUVICTO AND LUTATHERA
Context & Analysis
On Oct 8, 2025, Department of Veterans Affairs obligated $3,914,027.6 to NOVARTIS PHARMACEUTICALS CORPORATION for pluvicto and lutathera. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in LOS ANGELES, CA. The contract is scheduled through Oct 31, 2026 — approximately 5 months remaining.
Contractor Information
Contractor: NOVARTIS PHARMACEUTICALS CORPORATION
UEI: NG61ZA8TADW3
CAGE Code: 04520
Location: EAST HANOVER, NJ
Stay Updated
Get notified about new opportunities matching your interests.